Related references
Note: Only part of the references are listed.Virological, Serological, and Antiviral Studies in an Imported Human Case of Avian Influenza A(H7N9) Virus in Taiwan
Pi-Han Lin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study
Francisco M. Marty et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
The R292K Mutation That Confers Resistance to Neuraminidase Inhibitors Leads to Competitive Fitness Loss of A/Shanghai/1/2013 (H7N9) Influenza Virus in Ferrets
Hui-Ling Yen et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Impact of Potential Permissive Neuraminidase Mutations on Viral Fitness of the H275Y Oseltamivir-Resistant Influenza A(H1N1)pdm09 Virus In Vitro, in Mice and in Ferrets
Yacine Abed et al.
JOURNAL OF VIROLOGY (2014)
Amino Acid Substitutions in Polymerase Basic Protein 2 Gene Contribute to the Pathogenicity of the Novel A/H7N9 Influenza Virus in Mammalian Hosts
Chris Ka Pun Mok et al.
JOURNAL OF VIROLOGY (2014)
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Differences in the Pathogenicity and Inflammatory Responses Induced by Avian Influenza A/H7N9 Virus Infection in BALB/c and C57BL/6 Mouse Models
Guangyu Zhao et al.
PLOS ONE (2014)
A novel pyrosequencing assay for the detection of neuraminidase inhibitor resistance-conferring mutations among clinical isolates of avian H7N9 influenza virus
Yuhua Qi et al.
VIRUS RESEARCH (2014)
Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K
Chinh Tran-To Su et al.
BMC BIOINFORMATICS (2013)
Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses
Yan Wu et al.
CELL RESEARCH (2013)
Progressive emergence of an oseltamivir-resistant A (H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient
Aeron C. Hurt et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy
A. Piralla et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance
Yunwen Hu et al.
LANCET (2013)
The first case of H7N9 influenza in Taiwan
Sui-Yuan Chang et al.
LANCET (2013)
Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome
Yu Chen et al.
LANCET (2013)
Characterization of H7N9 influenza A viruses isolated from humans
Tokiko Watanabe et al.
NATURE (2013)
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
Rongbao Gao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Resistance to Neuraminidase Inhibitors Conferred by an R292K Mutation in a Human Influenza Virus H7N9 Isolate Can Be Masked by a Mixed R/K Viral Population
H. -L. Yen et al.
MBIO (2013)
Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility
Rong Hai et al.
NATURE COMMUNICATIONS (2013)
R292K Substitution and Drug Susceptibility of Influenza A(H7N9) Viruses
Katrina Sleeman et al.
EMERGING INFECTIOUS DISEASES (2013)
Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods
Ha T. Nguyen et al.
ANTIVIRAL THERAPY (2012)
Two mutations in the C-terminal domain of influenza virus RNA polymerase PB2 enhance transcription by enhancing cap-1 RNA binding activity
Shijian Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2012)
Peramivir for the treatment of influenza
Avinash K. Shetty et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Combinatorial Effect of Two Framework Mutations (E119V and I222L) in the Neuraminidase Active Site of H3N2 Influenza Virus on Resistance to Oseltamivir
Mathilde Richard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Frequency of Drug-resistant Viruses and Virus Shedding in Pediatric Influenza Patients Treated With Neuraminidase Inhibitors
Daisuke Tamura et al.
CLINICAL INFECTIOUS DISEASES (2011)
The I222V Neuraminidase Mutation Has a Compensatory Role in Replication of an Oseltamivir-Resistant Influenza Virus A/H3N2 E119V Mutant
Philippe Simon et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
MultiDrug-Resistant 2009 Pandemic Influenza A(H1N1) Viruses Maintain Fitness and Transmissibility in Ferrets
Matthew J. Memoli et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus Infection
Norio Sugaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Detection of E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir Resistance
Margaret Okomo-Adhiambo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Herc5 Attenuates Influenza A Virus by Catalyzing ISGylation of Viral NS1 Protein
YuJie Tang et al.
JOURNAL OF IMMUNOLOGY (2010)
Effect of the Neuraminidase Mutation H274Y Conferring Resistance to Oseltamivir on the Replicative Capacity and Virulence of Old and Recent Human Influenza A(H1N1) Viruses
Mariana Baz et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Oseltamivir-Resistant Variants of the 2009 Pandemic H1N1 Influenza A Virus Are Not Attenuated in the Guinea Pig and Ferret Transmission Models
Christopher W. Seibert et al.
JOURNAL OF VIROLOGY (2010)
ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells
Chen Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza Viruses
Aeron C. Hurt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an Immunocompromised child
Mariana Baz et al.
CLINICAL INFECTIOUS DISEASES (2006)
Resistant influenza A viruses in children treated with oseltarnivir: descriptive study
M Kiso et al.
LANCET (2004)
Overexpression of the α-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors
M Matrosovich et al.
JOURNAL OF VIROLOGY (2003)
Influenza virus carrying an R292K mutation in the neuraminidase gene is an transmitted in ferrets
ML Herlocher et al.
ANTIVIRAL RESEARCH (2002)
Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses
M Hatta et al.
SCIENCE (2001)
Share Paper
